You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 02 Apr 2026
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant, Adjuvant
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2026
Regimen
Published Date: 02 Apr 2026
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant, Adjuvant
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2026
Regimen
Published Date: 02 Apr 2026
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2026
Regimen
Published Date: 02 Apr 2026
Cancer Type:
Skin, 
Squamous Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2026
Regimen
Published Date: 02 Apr 2026
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2026
Regimen
Published Date: 02 Apr 2026
Cancer Type:
Head and Neck, 
Nasopharynx
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated to reflect that universal drug funding is available.

Updated
Apr 2026
Regimen
Published Date: 02 Apr 2026
Cancer Type:
Head and Neck, 
Nasopharynx
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated to reflect that universal drug funding is available.

Updated
Apr 2026
Regimen
Published Date: 02 Apr 2026
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant, Adjuvant
Revision Summary:

Regimen Monograph: Updated Intent, Rationale/uses, and Other Notes (DPD deficiency and fluorouracil antidote information) sections

Updated
Apr 2026
Drug

Published Date: 01 Apr 2026

Revision Summary:


Drug Monograph: Removed NDFP funding information

Updated
Apr 2026
Drug

Published Date: 01 Apr 2026

Revision Summary:


Drug Monograph: Removed NDFP funding information

Updated
Apr 2026
Regimen
Published Date: 31 Mar 2026
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Removed "Unfunded" info from bendamustine

Updated
Mar 2026
Regimen
Published Date: 31 Mar 2026
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Rationale/uses section; Removed bendamustine NDFP funding info

Updated
Mar 2026

Pages